Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Appropriately treating insomnia with triazolam.

V L Martin1

  • 1Catholic University, Louvain, Belgium.

Journal of Psychoactive Drugs
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Insomnia disrupts daily life, causing daytime sleepiness and reduced alertness. Triazolam, a short-acting benzodiazepine, offers an effective and safe treatment option for insomnia when used appropriately.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early infantile epileptic encephalopathy: a case associated with hemimegalencephaly.

Brain & development·1992
Same author

Time course of serum amyloid A response in myocardial infarction.

Clinica chimica acta; international journal of clinical chemistry·1989
Same author

Labia minora reduction in an iron-lung disabled woman.

Obstetrics and gynecology·1988
Same author

Cerebro-facio-thoracic dysplasia: report of three cases.

Developmental medicine and child neurology·1975
Same author

[Radiological investigation of tumors in the region of the chiasm and of the hypothalamus].

Annales de radiologie·1970
Same journal

Mystical Experiences as Catalysts in Ketamine-Assisted Psychotherapy: A Case Study.

Journal of psychoactive drugs·2026
Same journal

Cannabis-Induced Persistent Perceptual Disturbances: A Clinical Characterization Study of Multimodal Sensory Symptoms in 13 Patients.

Journal of psychoactive drugs·2026
Same journal

Specialist Inpatient Detoxification from Gabapentinoids: Clinical and Demographic Characteristics and Predictors of Outcome.

Journal of psychoactive drugs·2026
Same journal

Urine Prevalence of Psychoactive Substances, Nicotine Exposure and Associated Factors Among Commercial Drivers. An Exploratory Study.

Journal of psychoactive drugs·2026
Same journal

Latent Clusters of Peer Behaviors in Childhood and Relevance for Understanding Substance Use in Early Adolescence.

Journal of psychoactive drugs·2026
Same journal

Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States.

Journal of psychoactive drugs·2026
See all related articles

Area of Science:

  • Pharmacology
  • Sleep Medicine
  • Neurology

Background:

  • Insomnia is a prevalent sleep disorder characterized by difficulties falling asleep, staying asleep, or early morning awakening.
  • Sleep disturbances significantly impact daytime functioning, leading to fatigue, reduced alertness, and decreased quality of life.
  • Current insomnia management often requires individualized treatment approaches, including sleep hygiene and pharmacotherapy.

Purpose of the Study:

  • To evaluate the characteristics and therapeutic potential of triazolam as a hypnotic agent for insomnia.
  • To highlight the role of benzodiazepines in the pharmacological treatment of sleep disturbances.

Main Methods:

  • Review of pharmacological properties of triazolam, a triazolobenzodiazepine.
  • Assessment of triazolam's pharmacokinetic profile, including absorption, action duration, and elimination.
  • Consideration of clinical efficacy and safety based on appropriate prescription and dosage.

Main Results:

  • Triazolam exhibits pharmacological activity at target receptors, aligning with ideal hypnotic characteristics.
  • The drug demonstrates moderate absorption, short-acting effects, and rapid elimination.
  • When prescribed correctly and at appropriate dosages, triazolam is considered effective and safe.

Conclusions:

  • Triazolam possesses key pharmacological attributes making it a suitable option for managing insomnia.
  • An individualized approach to insomnia treatment is essential, with triazolam being a valuable therapeutic tool.
  • Proper medical guidance ensures the safe and effective use of triazolam for sleep disturbances.